Knight Therapeutics, Inc. (GUD.TO)
10.83
+0.10
(+0.93%)
CAD |
TSX |
Oct 09, 16:00
Knight Therapeutics Market Cap : 1.064B for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 1.064B |
| October 08, 2026 | 1.054B |
| October 07, 2026 | 1.052B |
| October 06, 2026 | 1.035B |
| October 05, 2026 | 1.018B |
| October 02, 2026 | 1.014B |
| October 01, 2026 | 1.045B |
| September 30, 2026 | 1.040B |
| September 29, 2026 | 1.017B |
| September 28, 2026 | 1.009B |
| September 25, 2026 | 1.011B |
| September 24, 2026 | 992.06M |
| September 23, 2026 | 991.08M |
| September 22, 2026 | 1.011B |
| September 21, 2026 | 999.92M |
| September 18, 2026 | 1.007B |
| September 17, 2026 | 1.005B |
| September 16, 2026 | 983.22M |
| September 15, 2026 | 978.31M |
| September 14, 2026 | 984.20M |
| September 11, 2026 | 967.50M |
| September 10, 2026 | 955.72M |
| September 09, 2026 | 972.41M |
| September 08, 2026 | 972.41M |
| September 04, 2026 | 983.22M |
| Date | Value |
|---|---|
| September 03, 2026 | 986.16M |
| September 02, 2026 | 949.82M |
| September 01, 2026 | 946.88M |
| August 31, 2026 | 948.84M |
| August 28, 2026 | 930.18M |
| August 27, 2026 | 941.96M |
| August 26, 2026 | 958.66M |
| August 25, 2026 | 957.68M |
| August 24, 2026 | 948.84M |
| August 21, 2026 | 948.84M |
| August 20, 2026 | 945.89M |
| August 19, 2026 | 964.56M |
| August 18, 2026 | 955.72M |
| August 17, 2026 | 960.63M |
| August 14, 2026 | 915.44M |
| August 13, 2026 | 904.64M |
| August 12, 2026 | 912.50M |
| August 11, 2026 | 933.12M |
| August 10, 2026 | 914.46M |
| August 07, 2026 | 958.66M |
| August 06, 2026 | 933.12M |
| August 05, 2026 | 909.55M |
| August 04, 2026 | 917.41M |
| July 31, 2026 | 966.80M |
| July 30, 2026 | 959.92M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| HLS Therapeutics, Inc. | 127.89M |
| Bausch Health Cos., Inc. | 3.231B |
| Cipher Pharmaceuticals, Inc. | 346.91M |
| BioSyent, Inc. | 194.49M |
| Revive Therapeutics Ltd. | 10.89M |
Market Cap Related Metrics
| PE Ratio | 72.10 |
| PS Ratio | 1.959 |
| PEG Ratio | 0.0157 |
| Price to Book Value | 1.332 |
| Price to Free Cash Flow | 10.83 |
| Price | 10.83 |
| Earnings Yield | 1.39% |
| PEGY Ratio | 0.0157 |
| Operating PE Ratio | 40.62 |
| Normalized PE Ratio | 53.46 |